Effect of renal impairment (RI) on intravenous bisphosphonates (IVBP) and multiple myeloma (MM) treatment.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e20007
Abstract: e20007Background: RI is prevalent in MM patients and associated with poor survival and increased costs. IVBPs are recommended to prevent skeletal-related event (SREs), a common and devastating comp... read more here.
Keywords: bisphosphonates ivbp; ivbp multiple; effect renal; intravenous bisphosphonates ... See more keywords